These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 10037502)

  • 1. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide.
    Bassan M; Zamostiano R; Davidson A; Pinhasov A; Giladi E; Perl O; Bassan H; Blat C; Gibney G; Glazner G; Brenneman DE; Gozes I
    J Neurochem; 1999 Mar; 72(3):1283-93. PubMed ID: 10037502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel signaling molecule for neuropeptide action: activity-dependent neuroprotective protein.
    Gozes I; Bassan M; Zamostiano R; Pinhasov A; Davidson A; Giladi E; Perl O; Glazner GW; Brenneman DE
    Ann N Y Acad Sci; 1999; 897():125-35. PubMed ID: 10676441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiserum to activity-dependent neurotrophic factor produces neuronal cell death in CNS cultures: immunological and biological specificity.
    Gozes I; Davidson A; Gozes Y; Mascolo R; Barth R; Warren D; Hauser J; Brenneman DE
    Brain Res Dev Brain Res; 1997 Apr; 99(2):167-75. PubMed ID: 9125470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design.
    Gozes I; Perl O; Giladi E; Davidson A; Ashur-Fabian O; Rubinraut S; Fridkin M
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):4143-8. PubMed ID: 10097177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A femtomolar-acting neuroprotective peptide.
    Brenneman DE; Gozes I
    J Clin Invest; 1996 May; 97(10):2299-307. PubMed ID: 8636410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel peptide prevents death in enriched neuronal cultures.
    Zemlyak I; Furman S; Brenneman DE; Gozes I
    Regul Pept; 2000 Dec; 96(1-2):39-43. PubMed ID: 11102650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective peptides that are orally active and mechanistically nonchiral.
    Brenneman DE; Spong CY; Hauser JM; Abebe D; Pinhasov A; Golian T; Gozes I
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1190-7. PubMed ID: 15007105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new concept in the pharmacology of neuroprotection.
    Gozes I; Brenneman DE
    J Mol Neurosci; 2000; 14(1-2):61-8. PubMed ID: 10854037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel VIP responsive gene. Activity dependent neuroprotective protein.
    Gozes I; Zamostiano R; Pinhasov A; Bassan M; Giladi E; Steingart RA; Brenneman DE
    Ann N Y Acad Sci; 2000; 921():115-8. PubMed ID: 11193814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A femtomolar-acting neuroprotective peptide induces increased levels of heat shock protein 60 in rat cortical neurons: a potential neuroprotective mechanism.
    Zamostiano R; Pinhasov A; Bassan M; Perl O; Steingart RA; Atlas R; Brenneman DE; Gozes I
    Neurosci Lett; 1999 Apr; 264(1-3):9-12. PubMed ID: 10320001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42).
    Gozes I; Divinski I; Piltzer I
    BMC Neurosci; 2008 Dec; 9 Suppl 3(Suppl 3):S3. PubMed ID: 19091000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAP alpha-aminoisobutyric acid (IsoNAP).
    Gozes I; Schirer Y; Idan-Feldman A; David M; Furman-Assaf S
    J Mol Neurosci; 2014 Jan; 52(1):1-9. PubMed ID: 24458740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The femtomolar-acting NAP interacts with microtubules: Novel aspects of astrocyte protection.
    Gozes I; Divinski I
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S37-41. PubMed ID: 15665412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze.
    Gozes I; Giladi E; Pinhasov A; Bardea A; Brenneman DE
    J Pharmacol Exp Ther; 2000 Jun; 293(3):1091-8. PubMed ID: 10869414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of ethanol antagonism and neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity.
    Wilkemeyer MF; Chen SY; Menkari CE; Brenneman DE; Sulik KK; Charness ME
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8543-8. PubMed ID: 12808140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of alcohol-induced learning deficits in the young adult in a model of fetal alcohol syndrome.
    Incerti M; Vink J; Roberson R; Wood L; Abebe D; Spong CY
    Obstet Gynecol; 2010 Feb; 115(2 Pt 1):350-356. PubMed ID: 20093910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects.
    Shiryaev N; Pikman R; Giladi E; Gozes I
    Curr Pharm Des; 2011; 17(25):2603-12. PubMed ID: 21728979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides.
    Brenneman DE; Hauser J; Neale E; Rubinraut S; Fridkin M; Davidson A; Gozes I
    J Pharmacol Exp Ther; 1998 May; 285(2):619-27. PubMed ID: 9580606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel tubulin and tau neuroprotective fragments sharing structural similarities with the drug candidate NAP (Davuentide).
    Gozes I; Iram T; Maryanovsky E; Arviv C; Rozenberg L; Schirer Y; Giladi E; Furman-Assaf S
    J Alzheimers Dis; 2014; 40 Suppl 1():S23-36. PubMed ID: 24503616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity-dependent neurotrophic factor (ADNF). An extracellular neuroprotective chaperonin?
    Gozes I; Brenneman DE
    J Mol Neurosci; 1996; 7(4):235-44. PubMed ID: 8968945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.